Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Guardix-sol for prevention of arm and shoulder morbidity after total mastectomy
KCT0000003Phase 4Recruiting
- Sponsor
- Hanmi Medicare
- Start
- Jul 2009
- Modality
- Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 4 trial of hyaluronic acid + carboxymethylcellulose in breast cancer, Breast carcinoma in situ (BCIS), sponsored by Hanmi Medicare. Started Jul 2009; status: recruiting.
02
Drugs
hyaluronic acid + carboxymethylcellulose
03
Conditions
breast cancerBreast carcinoma in situ (BCIS)
Beyond the preview
Go deeper on KCT0000003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000003.